|
Market Closed -
Nasdaq
01:30:00 29/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.200 USD | -0.83% |
|
-1.64% | -48.50% |
| 13/08 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 13/08 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 6.99Cr 6.02Cr 5.65Cr 5.15Cr 9.71Cr 667.89Cr 9.74Cr 67Cr 26Cr 337.15Cr 26Cr 26Cr 1.12TCr | P/E 2024 |
-0.81x | P/E 2025 | 15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 6.99Cr 6.02Cr 5.65Cr 5.15Cr 9.71Cr 667.89Cr 9.74Cr 67Cr 26Cr 337.15Cr 26Cr 26Cr 1.12TCr | EV / Sales 2024 |
11,70,430x | EV / Sales 2025 | - |
| Free-Float |
77.39% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Spero Therapeutics, Inc.
| 1 day | -0.83% | ||
| 1 week | -1.64% | ||
| Current month | +2.56% | ||
| 3 months | -57.60% | ||
| 6 months | -45.21% | ||
| Current year | -48.50% |
| 1 week | 1.18 |  | 1.26 |
| 1 month | 1.12 | | 1.3 |
| Current year | 1.08 | | 3.08 |
| 1 year | 1.08 | | 3.08 |
| 3 years | 0.51 | | 3.22 |
| 5 years | 0.51 | | 19.87 |
| 10 years | 0.51 | | 23.64 |
| Manager | Title | Age | Since |
|---|---|---|---|
Esther Rajavelu
CEO | Chief Executive Officer | 47 | 10/01/2025 |
Debra Zack
CTO | Chief Tech/Sci/R&D Officer | 69 | 27/07/2026 |
Timothy Keutzer
COO | Chief Operating Officer | 58 | 01/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Milind Deshpande
CHM | Chairman | 69 | 01/01/2014 |
| Director/Board Member | 62 | 01/09/2015 | |
Frank Thomas
CHM | Chairman | 56 | 10/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/08/26 | Free | Chief Technology Officer | 4,86,986 | 0.8411% | ||
| 04/05/26 | Sell | Chief Executive Officer | -25,240 | 0.0436% | ||
| 06/02/26 | Sell | Chief Executive Officer | 87,917 | 0.1560% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.83% | -1.64% | -42.03% | -16.67% | 6.99Cr | |
| -1.59% | -3.35% | +52.37% | +93.70% | 6.95TCr | |
| -1.34% | -0.75% | +48.21% | +92.23% | 6.5TCr | |
| +0.30% | -0.69% | +52.56% | +9.51% | 2.65TCr | |
| -2.35% | -5.75% | -12.90% | +436.87% | 2.59TCr | |
| -8.37% | -12.43% | +2.08% | -18.39% | 2.56TCr | |
| -0.96% | +10.36% | +283.06% | +429.04% | 2.02TCr | |
| -0.51% | +0.23% | +35.77% | -19.61% | 2TCr | |
| -1.91% | -4.37% | +13.28% | +557.93% | 1.57TCr | |
| -1.47% | +0.68% | +45.51% | +142.00% | 1.35TCr | |
| Average | -1.90% | -1.90% | +47.79% | +170.66% | 2.82TCr | |
| Weighted average by Cap. | -1.93% | -1.50% | +53.70% | +150.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.8Cr 4.13Cr 3.88Cr 3.54Cr 6.67Cr 458.54Cr 6.69Cr 46Cr 18Cr 231.47Cr 18Cr 18Cr 767.5Cr | 6.68Cr 5.76Cr 5.4Cr 4.93Cr 9.28Cr 638.45Cr 9.31Cr 64Cr 25Cr 322.29Cr 25Cr 25Cr 1.07TCr |
| Net income | -6.86Cr -5.91Cr -5.54Cr -5.06Cr -9.53Cr -655.31Cr -9.56Cr -66Cr -26Cr -330.8Cr -26Cr -25Cr -1.1TCr | 85.72L 73.86L 69.26L 63.22L 1.19Cr 82Cr 1.19Cr 8.22Cr 3.21Cr 41Cr 3.22Cr 3.15Cr 137.13Cr |
| Net Debt | - | - |
Employees
25
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $1.200 | -0.83% | 3,12,829 |
| 27/26/27 | $1.210 | -0.82% | 5,38,487 |
| 26/26/26 | $1.220 | -0.81% | 1,54,762 |
| 25/26/25 | $1.230 | +1.23% | 6,45,540 |
| 24/26/24 | $1.215 | -0.41% | 3,67,273 |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.200USD
Average target price
4.000USD
Spread / Average Target
+233.33%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRO Stock
Select your edition
All financial news and data tailored to specific country editions
